Markets
Goldman
@goldman_...
Bought ALNY
Shares
down -2.13%
At 275.0, Exited 269.1
Investing in ALNY seems promising due to its successful phase III study for Anvuttra in treating ATTR amyloidosis with cardiomyopathy, coupled with be...
Read
More
Thesis
Investing in ALNY seems promising due to its successful phase III study for Anvuttra in treating ATTR amyloidosis with cardiomyopathy, coupled with better-than-expected Q1 earnings and revenue. The strong drug pipeline and market momentum indicate potential further upside.
Go back
Tudor
@tudor-in...
Bought ALNY
Shares
up 10.47%
At 243.3, Now 245.1
Trims & Adds
[] Currently up $1.5M
[-] 52d ago
Trimmed 47.8K shares @
275.0
[+] 144d ago
Initial 60.4K shares @
243.0
Thesis
Go back
Two
@two-sigm...
Bought ALNY
Shares
up 48.28%
At 153.3, Now 245.1
Trims & Adds
[] Currently up $22.2M
[-] 52d ago
Trimmed 155.6K shares @
275.0
[-] 235d ago
Trimmed 300.0 shares @
153.0
[+] 144d ago
Added 69.1K shares @
243.0
[+] 235d ago
Initial 189.6K shares @
153.0
Thesis
Go back
Josh
@josh-got...
Bought ALNY
Shares
down -7.92%
At 195.1, Exited 179.6
Thesis
Go back
Point72
@point72-...
Bought ALNY
Shares
up 42.38%
At 194.9, Exited 243.0
Trims & Adds
[] Made $14.9M in profit
[-] 144d ago
All out @
243.0
[+] 235d ago
Added 120.3K shares @
153.0
[+] 326d ago
Initial 86.0K shares @
195.0
Thesis
Go back
Pinebridge
@pinebrid...
Bought ALNY
Shares
up 39.63%
At 179.0, Now 245.1
Trims & Adds
[] Currently up $932.4K
[-] 52d ago
Trimmed 688.0 shares @
275.0
[-] 144d ago
Trimmed 4.4K shares @
243.0
[+] 235d ago
Added 3.2K shares @
153.0
[+] 326d ago
Added 2.8K shares @
195.0
[+] 1.1y ago
Initial 7.4K shares @
179.0
Thesis
Go back
Two
@two-sigm...
Bought ALNY
Shares
up 22.46%
At 200.2, Now 245.1
Thesis
Go back
Duquesne
@duquesne...
Bought ALNY
Shares
down -2.52%
At 200.2, Exited 195.1
Thesis
Go back
